|
- Blood Biomarker-based Diagnostic Tools for Early Stage . . . - CORDIS
Funded by the Marie Skłodowska-Curie Actions programme, the BBDiag project aims to address this limitation by identifying AD biomarkers and developing specific detection methods
- Blood Biomarker-based Diagnostic Tools for Early-stage Alzheimer’s . . .
Despite intensive efforts, there are currently no disease-modifying treatments or preventive strategies for AD
- EU H2020 Project BBDIAG (Blood Biomarker-based Diagnostic Tools for . . .
BBDiag responds to such a need and establishes a much-needed ETN for blood based early-AD diagnostics to address these challenges It brings together leading academic and industrial experts from five major consortia in Europe and uses their synergies to build a triple-i research training platform with the required multidisciplinary expertise
- BBDiag :: European Project :: Up2Europe
BBDiag responds to such a need and establishes a much-needed ETN for blood based early-AD diagnostics to address these challenges It brings together leading academic and industrial experts from five major consortia in Europe and uses their synergies to build a triple-i research training platform with the required multidisciplinary expertise
- Blood Biomarker-based Diagnostic Tools for Early-stage Alzheimer鈥檚 . . .
Blood Biomarker-based Diagnostic Tools for Early-stage Alzheimer鈥檚 Disease responds to challenges in early stage diagnosis of AD and timely sets up an ETN with the required interdisciplinary expertise and cutting-edge technologies to provide a high quality triple-i (interdisciplinary, intersectoral and international) research platform for the training of a new generation of early-stage
- Classification of Alzheimer’s disease dementia (ADD) by using features . . .
Resting-state electroencephalography (rsEEG) provide topographic markers useful to assess the neurophysiological changes of the brain that correlate with the cognitive decline and dementia in AD patients
- Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s . . .
BBDiag responds to such a need and establishes a much-needed ETN for blood based early-AD diagnostics to address these challenges It brings together leading academic and industrial experts from five major consortia in Europe and uses their synergies to build a triple-i research training platform with the required multidisciplinary expertise
- Nanotechnology and biosensor diagnostics research
Blood Biomarker-based Diagnostic tools for early-stage Alzheimer’s disease BBDiag is a pan-European project led by the University of Plymouth, funded by Horizon 2020 Marie Curie programme that could revolutionise the effectiveness of Alzheimer’s diagnosis and clinical drug trials
|
|
|